Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.44 |
| ▸ | PPARG | P37231 | 7/20 | 0.44 |
| ▸ | PPARD | Q03181 | 7/20 | 0.44 |
| ▸ | PPARA | Q07869 | 7/20 | 0.44 |
| ▸ | TSHR | P16473 | 6/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TLR2 | O60603 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | FABP4 | P15090 | 2/20 | 0.44 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28152885 | 1.00 | CES2 (0.46) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL5692748 | 1.00 | CES2 (0.46) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL11973059 | 1.00 | CES2 (0.46) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL11973057 | 1.00 | CES2 (0.46) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL11792267 | 1.00 | CES2 (0.46) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL73314 | 0.97 | CES2 (0.43) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL10640262 | 0.97 | CES2 (0.43) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL30548776 | 0.89 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL31380881 | 0.89 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL30548802 | 0.89 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2678410-B1 | COMPOSIITONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES | PROCTER & GAMBLE (US) | 2017-09-13 | — | — | EP | disclosed |
| US-9193937-B2 | Mixtures of C10-C13 alkylphenyl sulfonates | THE PROCTER & GAMBLE COMPANY (US) | 2015-11-24 | — | — | US | disclosed |
| WO-2012138423-A1 | COMPOSITIONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES | THE PROCTER & GAMBLE COMPANY (US) | 2012-10-11 | — | — | WO | disclosed |
| US-20120214724-A1 | Mixtures OF C10-C13 Alkylphenyl Sulfonates | THE PROCTER & GAMBLE COMPANY | 2012-08-23 | — | — | US | disclosed |
| EP-0281399-B1 | ARYLHYDROXIDE ALKYLATION PROCESS | ETHYL CORPORATION (US) | 1992-01-08 | — | — | EP | disclosed |
| EP-0281399-A2 | Arylhydroxide alkylation process | ETHYL CORPORATION (US) | 1988-09-07 | — | — | EP | disclosed |
| US-4731492-A | Phenol alkylation process | ETHYL CORPORATION (US) | 1988-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120214724-A1 | Mixtures OF C10-C13 Alkylphenyl Sulfonates | SMURF1, C1S, SMURF2 | CES2 715/4885CES1 1392/4885GPR84 2144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.